跳到正文
原文
Gilead Sciences· @GileadSciences · X·· 16 小时前AI 评分40
AI 导读

#GileadNews:我们已签署自愿许可协议,以支持未来可能获得我们针对埃博拉本迪布焦病毒病的在研抗病毒药物。阅读更多:https://gilead.inc/4t6DoQL

正文

#GileadNews: We signed voluntary licensing agreements to support potential future access to our investigational antiviral for Ebola Bundibugyo virus disease. Read more: https://gilead.inc/4t6DoQL

来源:Gilead Sciences · x.com